• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Oral antithrombotic agents for the prevention of stroke in nonvalvular atrial fibrillation: a science advisory for healthcare professionals from the American Heart Association/American Stroke Association.

作者信息

Furie Karen L, Goldstein Larry B, Albers Gregory W, Khatri Pooja, Neyens Ron, Turakhia Mintu P, Turan Tanya N, Wood Kathryn A

出版信息

Stroke. 2012 Dec;43(12):3442-53. doi: 10.1161/STR.0b013e318266722a. Epub 2012 Aug 2.

DOI:10.1161/STR.0b013e318266722a
PMID:22858728
Abstract
摘要

相似文献

1
Oral antithrombotic agents for the prevention of stroke in nonvalvular atrial fibrillation: a science advisory for healthcare professionals from the American Heart Association/American Stroke Association.用于预防非瓣膜性心房颤动患者卒中的口服抗血栓药物：美国心脏协会/美国卒中协会给医疗保健专业人员的科学建议
Stroke. 2012 Dec;43(12):3442-53. doi: 10.1161/STR.0b013e318266722a. Epub 2012 Aug 2.
2
AHA/ASA publish advisory on oral antithrombotics for stroke prevention in nonvalvular artial fibrillation.美国心脏协会/美国卒中协会发布关于非瓣膜性心房颤动患者预防卒中的口服抗栓药物的咨询意见。
Am Fam Physician. 2013 May 15;87(10):732-3.
3
Design and rationale of Global Registry on Long-Term Oral Antithrombotic Treatment in Patients with Atrial Fibrillation: a global registry program on long-term oral antithrombotic treatment in patients with atrial fibrillation.《全球心房颤动患者长期口服抗栓治疗注册研究：一项关于心房颤动患者长期口服抗栓治疗的全球注册研究计划》
Am Heart J. 2014 Mar;167(3):329-34. doi: 10.1016/j.ahj.2013.12.006. Epub 2013 Dec 19.
4
'Real-world' antithrombotic treatment in atrial fibrillation: The EORP-AF pilot survey.“真实世界”的心房颤动抗栓治疗：EORP-AF 初步调查。
Am J Med. 2014 Jun;127(6):519-29.e1. doi: 10.1016/j.amjmed.2013.12.022. Epub 2014 Jan 28.
5
Antithrombotic therapy for stroke prevention in non-valvular atrial fibrillation.非瓣膜性心房颤动卒中预防的抗血栓治疗。
Lancet Neurol. 2012 Dec;11(12):1066-81. doi: 10.1016/S1474-4422(12)70258-2.
6
Antithrombotic treatment in real-life atrial fibrillation patients: a report from the Euro Heart Survey on Atrial Fibrillation.真实世界中房颤患者的抗栓治疗：欧洲房颤调查的报告
Eur Heart J. 2006 Dec;27(24):3018-26. doi: 10.1093/eurheartj/ehl015. Epub 2006 May 26.
7
Canadian Cardiovascular Society atrial fibrillation guidelines 2010: prevention of stroke and systemic thromboembolism in atrial fibrillation and flutter.加拿大心血管学会 2010 年心房颤动指南：预防心房颤动和心房扑动中的脑卒中及全身性血栓栓塞
Can J Cardiol. 2011 Jan-Feb;27(1):74-90. doi: 10.1016/j.cjca.2010.11.007.
8
Antithrombotic Treatment Patterns in Patients with Newly Diagnosed Nonvalvular Atrial Fibrillation: The GLORIA-AF Registry, Phase II.新发非瓣膜性心房颤动患者的抗血栓治疗模式：GLORIA-AF 登记研究，第二阶段。
Am J Med. 2015 Dec;128(12):1306-13.e1. doi: 10.1016/j.amjmed.2015.07.013. Epub 2015 Aug 1.
9
Is bleeding a necessary evil? The inherent risk of antithrombotic pharmacotherapy used for stroke prevention in atrial fibrillation.出血是一种必要的恶吗？用于心房颤动卒中预防的抗栓药物治疗的内在风险。
Expert Rev Cardiovasc Ther. 2013 Aug;11(8):1029-49. doi: 10.1586/14779072.2013.815423.
10
[Clinical characteristics and antithrombotic therapy for stroke prevention in patients with atrial fibrillation].[心房颤动患者预防卒中的临床特征及抗栓治疗]
Hokkaido Igaku Zasshi. 2002 Nov;77(6):563-70.

引用本文的文献

1
Direct Oral Anticoagulant Use in Older Adults with Atrial Fibrillation: Challenges and Solutions.老年心房颤动患者直接口服抗凝剂的使用：挑战与解决方案
Eur Cardiol. 2025 Feb 20;20:e03. doi: 10.15420/ecr.2024.17. eCollection 2025.
2
Two-Year Follow-Up of Patients With Atrial Fibrillation Receiving Edoxaban in Routine Clinical Practice: Results From the Global ETNA-AF Program.接受依度沙班治疗的房颤患者在常规临床实践中的两年随访：全球ETNA-AF项目的结果
Clin Cardiol. 2025 Feb;48(3):e70091. doi: 10.1002/clc.70091.
3
Prognosis of Patients With Ischemic Stroke With Prior Anticoagulant Therapy: Direct Oral Anticoagulants Versus Warfarin.
有抗凝治疗史的缺血性脑卒中患者的预后：直接口服抗凝剂与华法林。
J Am Heart Assoc. 2024 Aug 6;13(15):e034698. doi: 10.1161/JAHA.124.034698. Epub 2024 Aug 5.
4
Anesthetic Choice for Percutaneous Transcatheter Closure of the Left Atrial Appendage: A National Anesthesia Clinical Outcomes Registry Analysis.经皮左心耳封堵术的麻醉选择：国家麻醉临床结局登记分析。
Ann Card Anaesth. 2024 Jul 1;27(3):220-227. doi: 10.4103/aca.aca_14_24. Epub 2024 Jul 4.
5
Management of cerebral amyloid angiopathy and atrial fibrillation: We are still far from precision medicine.脑淀粉样血管病与心房颤动的管理：我们距离精准医学仍有很大差距。
World J Cardiol. 2024 May 26;16(5):231-239. doi: 10.4330/wjc.v16.i5.231.
6
Novel sizing role of 3D transesophageal echocardiography in a novel left atrial appendage clip device for patients undergoing video-assisted atrial fibrillation ablation: a cohort study.三维经食管超声心动图在一种用于视频辅助房颤消融患者的新型左心耳夹装置中的新型尺寸测量作用：一项队列研究。
Quant Imaging Med Surg. 2024 Feb 1;14(2):1335-1347. doi: 10.21037/qims-23-900. Epub 2024 Jan 18.
7
The Prevalence and Determinants of Inappropriate Oral Anticoagulant Use in Patients with Atrial Fibrillation, in Resource-Limited Setting.资源有限环境下，房颤患者不合理使用口服抗凝药物的流行情况及其决定因素。
Biomed Res Int. 2023 Dec 8;2023:6673397. doi: 10.1155/2023/6673397. eCollection 2023.
8
Assessment of Anticoagulant Initiation in Patients With New-Onset Atrial Fibrillation During Emergency Department Visit-Point-by-Point Response.评估急诊科就诊新发心房颤动患者的抗凝药物起始治疗——逐项回应。
Clin Appl Thromb Hemost. 2023 Jan-Dec;29:10760296231172493. doi: 10.1177/10760296231172493.
9
2021 ISHNE / HRS / EHRA / APHRS Collaborative Statement on mHealth in Arrhythmia Management: Digital Medical Tools for Heart Rhythm Professionals: From the International Society for Holter and Noninvasive Electrocardiology / Heart Rhythm Society / European Heart Rhythm Association / Asia Pacific Heart Rhythm Society.2021年国际动态心电图与无创心电学会/心律学会/欧洲心律协会/亚太心律协会关于移动健康在心律失常管理中的协作声明：面向心律专业人员的数字医疗工具：源自国际动态心电图与无创心电学会/心律学会/欧洲心律协会/亚太心律协会
Eur Heart J Digit Health. 2021 Jan 29;2(1):7-48. doi: 10.1093/ehjdh/ztab001. eCollection 2021 Mar.
10
Plasma apixaban levels in Chinese patients with chronic kidney disease-Relationship with renal function and bleeding complications.中国慢性肾脏病患者的血浆阿哌沙班水平——与肾功能及出血并发症的关系
Front Pharmacol. 2022 Dec 8;13:928401. doi: 10.3389/fphar.2022.928401. eCollection 2022.